Literature DB >> 15784546

Carbohydrate-binding specificity of the Escherichia coli cytolethal distending toxin CdtA-II and CdtC-II subunits.

Leslie A McSweeney1, Lawrence A Dreyfus.   

Abstract

Intoxication by cytolethal distending toxin depends on assembly of CdtB, the active A component of this AB toxin, with the cell surface-binding (B) component, composed of the CdtA-CdtC heterodimer, to form the active holotoxin. Here we examine the cell surface binding properties of Escherichia coli-derived CdtA-II (CdtA-II(Ec)) and CdtC-II(Ec) and their capacity to provide a binding platform for CdtB-II(Ec). Using a flow cytometry-based binding assay, we demonstrate that CdtB-II(Ec) binds to the HeLa cell surface in a CdtA-II(Ec)- and CdtC-II(Ec)-dependent manner and that CdtA-II(Ec) and CdtC-II(Ec) compete for the same structure on the HeLa cell surface. Preincubation of cells with glycoproteins (thyroglobulin and fetuin), but not simple sugars, blocks surface binding of CdtA-II(Ec) and CdtC-II(Ec). Moreover, CdtA-II(Ec) and CdtC-II(Ec) bind immobilized fetuin and thyroglobulin as well as fucose and to a lesser degree N-acetylgalactoseamine and N-acetylglucoseamine. Removal of N- but not O-linked carbohydrates from fetuin and thyroglobulin prevents binding of CdtA-II(Ec) and CdtC-II(Ec) to these glycoproteins. In addition, removal of N- but not O-linked surface sugar attachments prevents CDT-II(Ec) intoxication. To characterize the cell surface ligand recognized by CdtA-II(Ec) and CdtC-II(Ec), lectins having various carbohydrate specificities were used to block CDT activity and the cell surface binding of CdtA-II(Ec) and CdtC-II(Ec). Pretreatment of cells with AAA, SNA-I, STA, UEA-I, GNA, and NPA partially or completely blocked CDT activity. AAA, EEA, and UEA-I lectins, all having specificity for fucose, blocked surface binding of CdtA-II(Ec) and CdtC-II(Ec). Together, our data indicate that CdtA-II(Ec) and CdtC-II(Ec) bind an N-linked fucose-containing structure on HeLa cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784546      PMCID: PMC1087409          DOI: 10.1128/IAI.73.4.2051-2060.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Assembly and function of a bacterial genotoxin.

Authors:  Dragana Nesić; Yun Hsu; C Erec Stebbins
Journal:  Nature       Date:  2004-05-27       Impact factor: 49.962

2.  The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin.

Authors:  M Sugai; T Kawamoto; S Y Pérès; Y Ueno; H Komatsuzawa; T Fujiwara; H Kurihara; H Suginaka; E Oswald
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

3.  CdtA, CdtB, and CdtC form a tripartite complex that is required for cytolethal distending toxin activity.

Authors:  M Lara-Tejero; J E Galán
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Reconstitution and purification of cytolethal distending toxin of Actinobacillus actinomycetemcomitans.

Authors:  K Saiki; K Konishi; T Gomi; T Nishihara; M Yoshikawa
Journal:  Microbiol Immunol       Date:  2001       Impact factor: 1.955

5.  Cytolethal distending toxin demonstrates genotoxic activity in a yeast model.

Authors:  D C Hassane; R B Lee; M D Mendenhall; C L Pickett
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

6.  Evidence that Equine rhinitis A virus VP1 is a target of neutralizing antibodies and participates directly in receptor binding.

Authors:  S Warner; C A Hartley; R A Stevenson; N Ficorilli; A Varrasso; M J Studdert; B S Crabb
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin.

Authors:  D A Scott; J B Kaper
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

Review 8.  Lectin structure.

Authors:  J M Rini
Journal:  Annu Rev Biophys Biomol Struct       Date:  1995

9.  Glycosylation in human thyroglobulin: location of the N-linked oligosaccharide units and comparison with bovine thyroglobulin.

Authors:  S X Yang; H G Pollock; A B Rawitch
Journal:  Arch Biochem Biophys       Date:  1996-03-01       Impact factor: 4.013

10.  A diffusible cytotoxin of Haemophilus ducreyi.

Authors:  L D Cope; S Lumbley; J L Latimer; J Klesney-Tait; M K Stevens; L S Johnson; M Purven; R S Munson; T Lagergard; J D Radolf; E J Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

View more
  32 in total

1.  Cytolethal distending toxin family members are differentially affected by alterations in host glycans and membrane cholesterol.

Authors:  Aria Eshraghi; Francisco J Maldonado-Arocho; Amandeep Gargi; Marissa M Cardwell; Michael G Prouty; Steven R Blanke; Kenneth A Bradley
Journal:  J Biol Chem       Date:  2010-04-12       Impact factor: 5.157

2.  Crystallization of Escherichia coli CdtB, the biologically active subunit of cytolethal distending toxin.

Authors:  Jill S Hontz; Maria T Villar-Lecumberri; Lawrence A Dreyfus; Marilyn D Yoder
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-02-10

3.  Cytolethal distending toxin-induced cell cycle arrest of lymphocytes is dependent upon recognition and binding to cholesterol.

Authors:  Kathleen Boesze-Battaglia; Angela Brown; Lisa Walker; Dave Besack; Ali Zekavat; Steve Wrenn; Claude Krummenacher; Bruce J Shenker
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

4.  Cholesterol depletion reduces entry of Campylobacter jejuni cytolethal distending toxin and attenuates intoxication of host cells.

Authors:  Chia-Der Lin; Cheng-Kuo Lai; Yu-Hsin Lin; Jer-Tsong Hsieh; Yu-Ting Sing; Yun-Chieh Chang; Kai-Chuan Chen; Wen-Ching Wang; Hong-Lin Su; Chih-Ho Lai
Journal:  Infect Immun       Date:  2011-07-05       Impact factor: 3.441

5.  Chronic exposure to the cytolethal distending toxins of Gram-negative bacteria promotes genomic instability and altered DNA damage response.

Authors:  Riccardo Guidi; Lina Guerra; Laura Levi; Bo Stenerlöw; James G Fox; Christine Josenhans; Maria G Masucci; Teresa Frisan
Journal:  Cell Microbiol       Date:  2012-11-01       Impact factor: 3.715

Review 6.  Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages.

Authors:  Rasika N Jinadasa; Stephen E Bloom; Robert S Weiss; Gerald E Duhamel
Journal:  Microbiology (Reading)       Date:  2011-05-12       Impact factor: 2.777

7.  Role of intrachain disulfides in the activities of the CdtA and CdtC subunits of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans.

Authors:  Linsen Cao; Alla Volgina; Jonathan Korostoff; Joseph M DiRienzo
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

8.  Functional and structural characterization of chimeras of a bacterial genotoxin and human type I DNAse.

Authors:  Joseph M DiRienzo; Linsen Cao; Alla Volgina; Georges Bandelac; Jonathan Korostoff
Journal:  FEMS Microbiol Lett       Date:  2008-12-11       Impact factor: 2.742

9.  The Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin Active Subunit CdtB Contains a Cholesterol Recognition Sequence Required for Toxin Binding and Subunit Internalization.

Authors:  Kathleen Boesze-Battaglia; Lisa P Walker; Ali Zekavat; Mensur Dlakić; Monika Damek Scuron; Patrik Nygren; Bruce J Shenker
Journal:  Infect Immun       Date:  2015-07-27       Impact factor: 3.441

10.  Role of aromatic amino acids in receptor binding activity and subunit assembly of the cytolethal distending toxin of Aggregatibacter actinomycetemcomitans.

Authors:  Linsen Cao; Georges Bandelac; Alla Volgina; Jonathan Korostoff; Joseph M DiRienzo
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.